{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:39:19Z","timestamp":1740177559575,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":155,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ctarc.2024.100826","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:38:03Z","timestamp":1717598283000},"page":"100826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing the role of MSH2 and MSH6 gene expression deficiency in prostate cancer progression, a cross-sectional study"],"prefix":"10.1016","volume":"40","author":[{"given":"Fatemeh","family":"Sharbati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedieh Moradi","family":"Tabriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Nazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ctarc.2024.100826_bib0001","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.47391\/JPMA.7660","article-title":"Incidental prostate cancer: a 23-year review of a tertiary care hospital","volume":"73","author":"Khalique","year":"2023","journal-title":"J. Pak. Med. Assoc."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100826_bib0002","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur. Urol. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100826_bib0003","first-page":"539","article-title":"Roots of prostate cancer in African-American men","volume":"98","author":"Odedina","year":"2006","journal-title":"J. Natl. Med. Assoc."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100826_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-024-01427-6","article-title":"Prostate cancer presentation and management in the Middle East","volume":"24","author":"Sayan","year":"2024","journal-title":"BMC Urol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100826_bib0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/1055-9965.EPI-23-1034","article-title":"Trends of prostate cancer morbidity in low-incidence countries from 1990 to 2019","volume":"33","author":"Jiang","year":"2024","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ctarc.2024.100826_bib0006","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231216837","article-title":"The past and present of prostate cancer and its treatment and diagnostics: a historical review","volume":"11","author":"Lehtonen","year":"2023","journal-title":"SAGE Open. Med."},{"key":"10.1016\/j.ctarc.2024.100826_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare11202780","article-title":"The risk factors and screening uptake for prostate cancer: a scoping review","author":"Mumuni","year":"2023","journal-title":"Healthcare"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100826_bib0008","first-page":"151","article-title":"Prostate cancer pathology: recent updates and controversies","volume":"115","author":"Sehn","year":"2018","journal-title":"Mo Med."},{"key":"10.1016\/j.ctarc.2024.100826_bib0009","doi-asserted-by":"crossref","unstructured":"Tzelepi V. Prostate Cancer: Pathophysiology, Pathology and Therapy. Cancers. 2022;15(1):281.","DOI":"10.3390\/cancers15010281"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100826_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumors of the urinary system and male genital organs\u2014Part B: prostate and bladder tumors","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100826_bib0011","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1389201022666210615123211","article-title":"Recent advances in siRNA delivery systems for prostate cancer therapy","volume":"23","author":"Aghamiri","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100826_bib0012","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1007\/s10238-023-01159-1","article-title":"The impact of ECOG performance status on the efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study","volume":"23","author":"Mollica","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100826_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030546","article-title":"Bone targeting agents in patients with metastatic prostate cancer: state of the art","volume":"13","author":"Mollica","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100826_bib0014","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17425255.2022.2072727","article-title":"Incidence of grade 3-4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis","volume":"18","author":"Rizzo","year":"2022","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100826_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041551","article-title":"Treating prostate cancer by antibody-drug conjugates","volume":"22","author":"Rosellini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.ctarc.2024.100826_bib0016","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020124","article-title":"Loss of DNA mismatch repair proteins in prostate cancer","volume":"99","author":"Sharma","year":"2020","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100826_bib0017","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/14737159.2016.1156533","article-title":"Mismatch repair deficiency testing in clinical practice","volume":"16","author":"Buza","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100826_bib0018","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41598-018-20557-0","article-title":"ATP-dependent conformational change in ABC-ATPase RecF serves as a switch in DNA repair","volume":"8","author":"Tang","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100826_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317725834","article-title":"Prevalence and prognostic role of mismatch repair gene defect in endometrial cancer patients","volume":"39","author":"Tangjitgamol","year":"2017","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100826_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41698-024-00560-7","article-title":"Development and validation of a deep learning-based microsatellite instability predictor from prostate cancer whole-slide images","volume":"8","author":"Hu","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100826_bib0021","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cam4.2702","article-title":"Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences","volume":"9","author":"Chang","year":"2020","journal-title":"Cancer Med."},{"issue":"19","key":"10.1016\/j.ctarc.2024.100826_bib0022","doi-asserted-by":"crossref","first-page":"e20124","DOI":"10.1097\/MD.0000000000020124","article-title":"Loss of DNA mismatch repair proteins in prostate cancer","volume":"99","author":"Sharma","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.ctarc.2024.100826_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijso.2021.100430","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional, and case-control studies in surgery","volume":"37","author":"Mathew","year":"2021","journal-title":"Int. J. Surg. Open"},{"issue":"12","key":"10.1016\/j.ctarc.2024.100826_bib0024","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jamaoncol.2020.4922","article-title":"Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging collaboration for cancer of the prostate","volume":"6","author":"Dess","year":"2020","journal-title":"JAMa Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100826_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13000-024-01447-8","article-title":"Rare germline mutation and MSH2-&MSH6+ expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report","volume":"19","author":"Zhang","year":"2024","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.ctarc.2024.100826_bib0026","article-title":"Stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6: hereditary cancer syndrome?","author":"P\u00e9rez","year":"2023","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100826_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34208","article-title":"Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer","volume":"6","author":"Hwang","year":"2023","journal-title":"JAMa Netw. Open"},{"issue":"7","key":"10.1016\/j.ctarc.2024.100826_bib0028","article-title":"An evaluation of the immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate adenocarcinoma","volume":"14","author":"Javeed","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100826_bib0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/carcin\/bgw116","article-title":"Up-regulation of mismatch repair genes MSH6, PMS2, and MLH1 parallels the development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer","volume":"38","author":"Wilczak","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ctarc.2024.100826_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00428-019-02591-z","article-title":"Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status","volume":"475","author":"Albero-Gonz\u00e1lez","year":"2019","journal-title":"Virchows Arch."},{"issue":"22","key":"10.1016\/j.ctarc.2024.100826_bib0031","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1158\/1078-0432.CCR-17-0955","article-title":"MSH2 loss in primary prostate cancer","volume":"23","author":"Guedes","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2024.100826_bib0032","article-title":"Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100826_bib0033","first-page":"115","article-title":"Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation","volume":"5","author":"McCarthy","year":"2019","journal-title":"J. Pathol.: Clin. Res."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:26:41Z","timestamp":1725089201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294224000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":33,"alternative-id":["S2468294224000388"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100826","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the role of MSH2 and MSH6 gene expression deficiency in prostate cancer progression, a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100826"}}